Answers are grounded in this paper and cite their sources.
Pneumocystis pneumonia (PCP) is a serious opportunistic infection that requires rapid and reliable diagnostics. For this, we evaluated three commercial assays for Pneumocystis jirovecii detection in 82 patient-derived respiratory specimens: two qPCR assays and a loop-mediated isothermal amplification (LAMP) assay. The qPCR assays demonstrated high concordance, with sensitivities of 98.0% and 100%. Most discrepancies were observed in samples with low amounts of P. jirovecii DNA (Ct > 34). In our material, the LAMP assay showed substantially lower sensitivity (16.0%), compared with 38–95.7% observed in previous reports. Nevertheless, specificity of LAMP test was high (100%), and the assay performed well with samples containing high amount of P. jirovecii DNA, offering a rapid analysis time ranging from 3 to 25 min. Following the local implementation of P. jirovecii PCR testing in our area in 2021, turnaround time (TAT) decreased from four to two days while the number of samples tested increased 2.3-fold, reflecting changes in clinical practice. Indeed, the amount of annual sampling for P. jirovecii in respiratory specimens has gradually increased in our area, while the number of P. jirovecii positive samples has not increased. Overall, our results would suggest that the qPCR assays provide reliable detection of P. jirovecii DNA in clinical samples, while the LAMP assay might serve as a complementary point-of-care tool in the diagnostic workflow for PCP.
No takes yet. Share an insight, caveat, or question.
Aho-Laukkanen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: